comparemela.com
Home
Live Updates
BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate : comparemela.com
BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate
/PRNewswire/ -- BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the first patient has been dosed in the Phase I Clinical...
Related Keywords
China ,
Hangzhou ,
Zhejiang ,
San Diego ,
California ,
United States ,
Erwei ,
Jiangsu ,
Taizhou ,
Shanghai ,
Zhu Wei ,
Yao Herui ,
Prnewswire Bioray Pharmaceutical Co Ltd ,
,
Phasei Clinical ,
Sun Yat Sen Memorial Hospital ,
Sun Yat Sen University ,
Song Erwei ,
Professor Yao ,
Bioray Pharmaceutical Co ,
Td ,
comparemela.com © 2020. All Rights Reserved.